369 related articles for article (PubMed ID: 26504373)
1. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
5. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
6. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease.
Ardah MT; Bharathan G; Kitada T; Haque ME
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172035
[TBL] [Abstract][Full Text] [Related]
7. Oral Supplements of
Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
[TBL] [Abstract][Full Text] [Related]
8. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.
Ojha S; Javed H; Azimullah S; Haque ME
Mol Cell Biochem; 2016 Jul; 418(1-2):59-70. PubMed ID: 27316720
[TBL] [Abstract][Full Text] [Related]
9. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
Sharma S; Kumar P; Deshmukh R
Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
13. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
Zhang G; Yang G; Liu J
Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998
[TBL] [Abstract][Full Text] [Related]
14. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
Kandil EA; Abdelkader NF; El-Sayeh BM; Saleh S
Neuroscience; 2016 Sep; 332():26-37. PubMed ID: 27365173
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X
Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
El-Sayed EK; Ahmed A; Morsy EE; Nofal S
Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
